Epstein-Barr virus-associated gastric carcinoma

Pathology Research and Practice

Volumn 207, Issue 9, 2011, Pages

  Fukayama, Masashi ^a   Ushiku, Tetsuo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

DNA methylation; Epigenetics; Epstein Barr virus; Gastric cancer; LMP2A; Virus host interaction

Indexed keywords

CELL DNA; DNA METHYLTRANSFERASE 1; PROTEIN LMP2A; REGULATOR PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

CANCER RISK; CANCER STAGING; CARCINOMA CELL; CELL GROWTH; CLINICAL FEATURE; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; EPIGENETICS; EPITHELIUM CELL; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION; GENE REPRESSION; GENETIC DISORDER; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; LYMPHOCYTIC INFILTRATION; LYMPHOEPITHELIOMA; MACROPHAGE MIGRATION; NONHUMAN; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PTEN GENE; REVIEW; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH EPITHELIUM; STOMACH MUCOSA; STOMACH SURGERY; TUMOR SUPPRESSOR GENE; UPREGULATION; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS LATENCY;

ADENOCARCINOMA; CARCINOMA; CPG ISLANDS; DNA METHYLATION; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; MEMBRANE PROTEINS; PHOSPHORYLATION; PTEN PHOSPHOHYDROLASE; REPRESSOR PROTEINS; STAT3 TRANSCRIPTION FACTOR; STOMACH NEOPLASMS; UP-REGULATION; VIRAL MATRIX PROTEINS;

EID: 80054003491     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.07.004     Document Type: Review

References (63)

1. Epstein M.A., Barr Y.M., Achong B.G. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964, 15:702-703.
2. Young L.S., Rickinson A.B. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 2004, 4:757-768.
3. Uozaki H., Fukayama M. Epstein-Barr virus associated gastric carcinoma-viral carcinogenesis through epigenetic mechanisms. Int. J. Clin. Exp. Pathol. 2008, 1:198-216.
4. Fukayama M., Hino R., Uozaki H. Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma. Cancer Sci. 2008, 99:1726-1733.
5. Akiba S., Koriyama C., Herrera-Goepfert R., Eizuru Y. Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features. Cancer Sci. 2008, 99:195-201.
6. Murphy G., Pfeiffer R., Camargo M.C., Rabkin C.S. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology 2009, 137:824-833.
7. Ohgaki H., Matsukura N. Stomach cancer. World Cancer Report 2003, 194-197. IARC Press, Lyon. B.W. Stewart, P. Kleihues (Eds.).
8. Lee J.H., Kim S.H., Han S.H., An J.S., Lee E.S., Kim Y.S. Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis. J. Gastroenterol. Hepatol. 2009, 24:354-365.
9. Maeda E., Akahane M., Uozaki H., Kato N., Hayashi N., Fukayama M., Ohtomo K. CT appearance of Epstein-Barr virus-associated gastric carcinoma. Abdom. Imaging 2009, 34:618-625.
10. van Beek J., zur Hausen A., Klein Kranenbarg E., van de Velde C.J., Middeldorp J.M., van den Brule A.J., Meijer C.J., Bloemena E. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J. Clin. Oncol. 2004, 22:664-670.
11. Tokunaga M., Land C.E. Epstein-Barr virus involvement in gastric cancer: biomarker for lymph node metastasis. Cancer Epidemiol. Biomark. Prevent. 1998, 7:449-450.
12. Yamamoto N., Tokunaga M., Uemura Y., Tanaka S., Shirahama H., Nakamura T., Land C.E., Sato E. Epstein-Barr virus and gastric remnant cancer. Cancer 1994, 74:805-809.
13. Baas I.O., van Rees B.P., Musler A., Craanen M.E., Tytgat G.N.J., vanden Berg F.M., Offerhaus G.J.A. Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach. J. Clin. Pathol. 1998, 51:662-666.
14. Chang M.S., Lee J.H., Kim J.P., Lee H.S., Kim C.W., Kim Y.I., Kim W.H. Microsatellite instability and Epstein-Barr virus infection in gastric remnant cancers. Pathol. Int. 2000, 50:486-492.
15. Nishikawa J., Yanai H., Hirano A., Nakamura H., Matsusaki K., Kawano T., Miura O., Okita K. High prevalence of Epstein-Barr virus in gastric remnant carcinoma after Billroth-II reconstruction. Scand. J. Gastroenterol. 2002, 37:825-829.
16. Tanigawa H., Uesugi H., Mitomi H., Saigenji K., Okayasu I. Possible association of active gastritis, featuring accelerated cell turnover and p53 overexpression, with cancer development at anastomoses after gastrojejunostomy. Comparison with gastroduodenostomy. Am. J. Clin. Pathol. 2000, 114:354-363.
17. Kaizaki Y., Hosokawa O., Sakurai S., Fukayama M. Epstein-Barr virus-associated gastric carcinoma in the remnant stomach: de novo and metachronous gastric remnant carcinoma. J. Gastroenterol. 2005, 40:570-577.
18. Tokunaga M., Land C.E., Uemura Y., Tokudome T., Tanaka S., Sato E. Epstein-Barr virus in gastric carcinoma. Am. J. Pathol. 1993, 143:1250-1254.
19. Chang M.S., Lee H.S., Kim H.S., Kim S.H., Choi S.I., Lee B.L., Kim C.W., Kim Y.I., Yang M., Kim W.H. Epstein-Barr virus and microsatellite instability in gastric carcinogenesis. J. Pathol. 2003, 199:447-452.
20. Matsunou H., Konishi F., Hori H., Ikeda T., Sasaki K., Hirose Y., Yamamichi N. Characteristics of Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma in Japan. Cancer 1996, 77:1998-2004.
21. Kaizaki Y., Sakurai S., Chong J.M., Fukayama M. Atrophic gastritis Epstein-Barr virus infection, and Epstein-Barr virus-associated gastric carcinoma. Gastric Cancer 1999, 2:101-108.
22. Shibata D., Tokunaga M., Uemura Y., Sato E., Tanaka S., Weiss L.M. Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am. J. Pathol. 1991, 139:469-474.
23. Watanabe H., Enjoji M., Imai T. Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations. Cancer 1976, 38:232-243.
24. Shibata D., Weiss L.M. Epstein-Barr virus-associated gastric adenocarcinoma. Am. J. Pathol. 1992, 140:769-774.
25. Oda K., Tamaru J., Takenouchi T., Mikata A., Nunomura M., Saitoh N., Sarashina H., Nakajima N. Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. Am. J. Pathol. 1993, 143:1063-1071.
26. Nakamura S., Ueki T., Yao T., Ueyama T., Tsuneyoshi M. Epstein-Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis. Cancer 1994, 73:2239-2249.
27. Qui K., Tomita Y., Hashimoto M., Ohsawa M., Kawano K., Wu D.M., Aozasa K. Epstein-Barr virus in gastric carcinoma in Suzhou, China and Osaka Japan: association with clinico-pathological factors and HLA-subtype. Int. J. Cancer 1997, 71:155-158.
28. Galetsky S.A., Tsvetnov W., Land C.E., Afanasieva T.A., Petrovichev V.E., Tokunaga M. Epstein-Barr-virus-associated cancer in Russia. Int. J. Cancer 1997, 73:786-789.
29. Wu M.S., Shun C.T., Wu C.C., Hsu T.Y., Lin M.T., Chang M.C., Wang H.P., Lin J.T. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. Gastroenterology 2000, 118:1031-1038.
30. Chang M.S., Lee H.S., Kin C.W., Kim Y.I., Kim W.H. Clinocopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea. Pathol. Res. Pract. 2001, 197:395-400.
31. Burguss D.E., Woodman C.B., Rowlands D.C., Crocker J., Scott K., Biddulph J.P., Young L.S., Murray P.G. Low prevalence of Epstein-Barr virus in incident gastric adenocarcinomas in the United Kingdom. Br. J. Cancer 2002, 86:702-704.
32. Corvalan A., Koriyama C., Akiba S., Eizuru Y., Backhouse C., Palma M., Argandona J., Tokunaga M. Epstein-Barr virus in gastric carcinoma is associated with location in the cardia and with diffuse histology; a study in one area of Chile. Int. J. Cancer 2001, 94:527-530.
33. Kijima Y., Hokita S., Takao S., Baba M., Natsugoe S., Yoshinaka H., Aridome K., Otsuji T., Itoh T., Tokunaga M., Eizuru Y., Aikou T. Epstein-Barr virus involvement is mainly restricted to lymphoepithelial type of gastric carcinoma among various epithelial neoplasms. J. Med. Virol. 2001, 64:513-518.
34. Herrera-Gepfert R., Akiba S., Koriyama C., Ding S., Reyes E., Itoh T., Minakami Y., Eizuru Y. Epstein-Barr virus-associated gastric carcinoma: evidence of age-dependence among a Mexican population. World J. Gastroenterol. 2005, 11. 6-96-103.
35. Grogg K.L., Lohse C.M., Pankratz V.S., Halling K.C., Smyrk T.C. Lymphocyte-rich gastric cancer; associations with Epstein-Barr virus, microsatellite instability, histology, and survival. Mod. Pathol. 2003, 16:641-651.
36. Arikawa J., Tokunaga M., Satoh E., Tanaka S., Land C.E. Morphological characteristics of Epstein-Barr virus-related early gastric carcinoma: a case-control study. Pathol. Int. 1997, 47:360-367.
37. Shinozaki A., Ushiku T., Fukayama M. Prominent Mott cell proliferation in Epstein-Barr virus associated gastric carcinoma. Hum. Pathol. 2010, 41:134-138.
38. Fukayama M. Epstein-Barr virus associated gastric carcinoma. Pathol. Int. 2010, 60:337-350.
39. Shinozaki A., Ushiku T., Morikawa T., Hino R., Sakatani T., Uozaki H., Fukayama M. Epstein-Barr virus-associated gastric carcinoma: a distinct carcinoma of gastric phenotype by claudin expression profiling. J. Histochem. Cytochem. 2009, 57:775-785.
40. Barua R.R., Uozaki H., Chong J.M., et al. Phenotype analysis by MUC2, MUC5AC MUC6, and CD10 expression in Epstein-Barr virus-associated gastric carcinoma. J. Gastroenterol. 2006, 41:733-739.
41. Yoshiyama H., Imai S., Shimizu N., Takada K. Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J. Virol. 1997, 71:5688-5691.
42. Imai S., Nishikawa J., Takada K. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J. Virol. 1998, 72:4371-4378.
43. Fukayama M., Hayashi Y., Iwasaki Y., et al. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab. Invest. 1994, 71:73-81.
44. Hayashi K., Teramoto N., Akagi T., Sasaki Y., Suzuki T. In situ detection of Epstein-Barr virus in the gastric glands with intestinal metaplasia. Am. J. Gastroenterol. 1996, 91:1481.
45. Saiki Y., Otani H., Naito Y., Miyazawa M., Nagura H. Immunophenotypic characterization of Epstein-Barr virus-associated gastric carcinoma: massive infiltration by proliferating CD8+ T-lymphocytes. Lab. Invest. 1996, 75:67-76.
46. Kuzushima K., Nakamura S., Nakamura T., et al. Increased frequency of antigen-specific CD8(+) cytotoxic T lymphocytes infiltrating an Epstein-Barr virus-associated gastric carcinoma. J. Clin. Invest. 1999, 104:163-171.
47. Chong J.M., Sakuma K., Sudo M., et al. Interleukin-1beta expression in human gastric carcinoma with Epstein-Barr virus infection. J. Virol. 2002, 76:6825-6831.
48. El-Omar E.M., Carrington M., Chow W.H., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404:398-402. (Erratum in: Nature 2001;412:99).
49. Esteller M. Epigenetics in cancer. N. Engl. J. Med. 2008, 358:1148-1159.
50. Kaneda A., Kaminishi M., Yanagihara K., Sugimura T., Ushijima T. Identification of silencing of nine genes in human gastric cancers. Cancer Res. 2002, 62:6645-6650.
51. Chang M.S., Uozaki H., Chong J.M., et al. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Clin. Cancer Res. 2006, 12:2995-3002.
52. Chong J.-M., Fukayama M., Hayashi Y., Takizawa T., Koike M., Konishi M., et al. Microsatellite instability in the progression of gastric carcinoma. Cancer Res. 1994, 54:4595-4597.
53. Hino R., Uozaki H., Inoue Y., Shintani Y., Ushiku T., Sakatani T., Takada K., Fukayama M. Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A. Cancer Res. 2008, 68:1427-1435.
54. Hino R., Uozaki H., Murakami N., et al. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res. 2009, 69:2766-2774.
55. Ernst M., Najdovska M., Grail D., Lundgren-May T., Buchert M., Tye H., Matthews V.B., Armes J., Bhathal P.S., Hughes N.R., Marcusson E.G., Karras J.G., Na S., Sedwick J.D., Hertzog P.J., Jenkins B.J. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J. Clin. Invest. 2008, 118:1727-1738.
56. Li H., Minarovits J. Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation. Adv. Cancer Res. 2003, 89:133-156.
57. Niller H.H., Wolf H., Minarovits J. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia. Semin. Cancer Biol. 2009, 19:158-164.
58. Feinberg A.P., Ohlsson R., Henikoff S. The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 2006, 7:21-33.
59. Enomoto S., Maekita T., Tsukamoto T., et al. Lack of association between CpG island methylator phenotype in human gastric cancers and methylation in their background non-cancerous gastric mucosae. Cancer Sci. 2007, 98:1853-1861.
60. Ushiku T., Chong J.M., Uozaki H., et al. p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma. Int. J. Cancer 2007, 120:60-66.
61. Fu D.X., Tanhehco Y.C., Chen J., et al. Bortezomib-induced enzyme-targeted radiotherapy in herpes virus-associated tumors. Nat. Med. 2008, 1118-1122.
62. Jung E.J., Lee Y.M., Lee B.L., Chang M.S., Kim W.H. Lytic induction and apoptosis of Epstein-Barr virus-associated gastric cancer cell line with epigenetic modifiers and ganciclovir. Cancer Lett. 2007, 247:77-83.
63. Ushiku T., Shinozaki A., Uozaki H., Iwasaki Y., Tateishi Y., Funata N., Seto Y., Fukayama M. Gastric carcinoma with osteoclast-like giant cells. Lymphoepithelioma-like carcinoma with Epstein-Barr virus infection is the predominant type. Pathol Int. 2010, 60:551-558.